Consumer staples often get lumped together as a defensive category, yet the Fidelity MSCI Consumer Staples Index ETF (FSTA) and the First Trust Consumer Staples AlphaDEX Fund (FXG) follow very different construction methods. FSTA tracks a broad index in a straightforward, low-cost manner, while FXG applies a quantitative screen to select and weight a narrower group of names. As inflation, rate expectations, and consumer spending patterns continue to shift, understanding these structural differences helps clarify how each fund might fit into a portfolio.
FSTA seeks to match the MSCI USA IMI Consumer Staples 25/50 Index, a market-cap-weighted benchmark that covers large-, mid-, and small-cap U.S. staples companies. The fund holds around 100 securities, almost entirely in consumer defensive names. Its largest holdings reflect a clear mega-cap bias, with WMT, COST, PG, KO, and PEP making up a substantial portion, followed by PM, MO, MDLZ, CL, and MNST. The expense ratio stands at 0.08%, one of the lowest in the category, and the fund’s asset size supports tight spreads and strong liquidity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
FXG follows the StrataQuant Consumer Staples Index, which uses the AlphaDEX methodology on the Russell 1000 universe. Stocks are ranked on growth factors such as price appreciation, sales growth, and sales-to-price, along with value factors including book-to-price, cash-flow-to-price, and return on assets. Higher-ranked names receive heavier weights in a modified equal-dollar portfolio of about 41 holdings that is rebalanced quarterly. Typical top positions include CAH, FRPT, POST, PPC, MKC, INGR, SFD, and STZ, each around 4%. The screen also brings in distribution and healthcare-adjacent names such as MCK, giving FXG a meaningful healthcare allocation. Its expense ratio is 0.63%, and the smaller asset base leads to lighter trading volume.
The consumer staples sector has long served as a defensive holding during uncertain times. Recent periods have introduced pressure from input-cost inflation, cautious spending, and trade dynamics affecting packaged goods. Branded companies have faced private-label competition and volume softness, yet the group’s steady cash flows and dividends remain appealing when yields and stability are prioritized. In this setting, the contrast between FSTA’s broad mega-cap quality exposure and FXG’s factor-tilted mid-cap focus has become more pronounced, with the index approach showing steadier performance in recent months.
Over recent weeks and months, FSTA has shown more consistent trend behavior, supported by its concentration in large, well-capitalized names with pricing power. FXG’s tilt toward mid-cap food, agricultural, and distribution companies has left it more exposed to commodity swings and company-specific surprises. FSTA’s mega-cap orientation and deeper liquidity generally translate to lower relative drawdowns, while FXG’s concentrated roster can amplify short-term volatility. The expense gap—0.08% for FSTA versus 0.63% for FXG—creates a structural advantage that compounds over time. Sector rotation toward defensive quality has favored FSTA’s holdings, whereas FXG has been more sensitive to food-commodity prices and healthcare distribution trends.
I find it helpful to run periodic checks with Tickeron’s AI Screener when comparing sector ETFs. The tool lets me apply technical, fundamental, and trend filters across thousands of names in a structured way, which can surface relative strengths or risks that might otherwise take longer to identify manually. In this case it reinforced the liquidity and cost advantages already visible in the data.
Based on the structural factors at hand, the current preference leans toward FSTA. It combines a materially lower expense ratio, a broader and more liquid portfolio, greater diversification, and a mega-cap quality tilt that has supported steadier trends through recent cycles. FXG’s factor methodology remains a reasonable option for those seeking explicit value and growth tilts within staples, yet its higher cost, concentrated holdings, thinner volume, and greater sensitivity to commodity and idiosyncratic risks create a relative disadvantage in the present environment. Overall, FSTA offers the stronger combination of cost efficiency, diversification, and risk-adjusted positioning between the two.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where FXG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on FXG as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples